Miau Labs / Insight
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
Miles Wang, an OpenAI researcher, is leaving the company to launch a new startup focused on developing AI models for drug discovery. The startup is expected to raise $200 million at a $2 billion valuation, with Lightspeed potentially leading the funding round.
Miles Wang, an OpenAI researcher, is leaving the company to launch a new startup focused on developing AI models for drug discovery. The startup is expected to raise $200 million at a $2 billion valuation, with Lightspeed potentially leading the funding round. Wang's new startup may be an opportunity to apply AI in drug discovery and find new uses for existing drugs, resulting in a significantly faster time to revenue.
Miles Wang, an OpenAI researcher, is leaving the company to launch a new startup focused on developing AI models for drug discovery. The startup is expected to raise $200 million at a $2 billion valuation, with Lightspeed potentially leading the funding round.
- Miles Wang, an OpenAI researcher, is leaving the company to launch a new startup focused on developing AI models for drug discovery.
- The startup is expected to raise $200 million at a $2 billion valuation, with Lightspeed potentially leading the funding round.
- Wang's new startup may focus on finding new uses for existing drugs and possibly those that previously failed in trials, resulting in a significantly faster time to revenue.
Miau Labs takeWang's new startup may be an opportunity to apply AI in drug discovery and find new uses for existing drugs, resulting in a significantly faster time to revenue.